Insmed (INSM) Stock Price, Quote, News & History | Benzinga

Insmed Inc (INSM) Stock Price, Quote, News & History

INSMNASDAQ

Trade with Public

Trade with Public

$121.39

-3.00-2.41%

At close: Aug 26, 5:00 PM EST

$128.52

4.133.32%

Pre-Market: 4:02 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$121.39

Volume / Avg.

867.00 / 3.43M

Day Range

- - -

52 Wk Range

90.39 - 212.75

Market Cap

$28.07B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

5.62%

Days to Cover

2.66

Recent Insmed Incorporated News

Biotech Is Booming, But These 2 Stocks Missed the Memo

The iShares Biotechnology ETF is trading at new highs and 18 out of its top 20 constituents are green for the year.

Erica Kollmann

S&P 500, Dow Fall as Brent Jumps 4%, SanDisk Trims Losses: Stock Market Today

Crude's rebound on Yemen strikes pulled U.S. equities off record highs Thursday, while SanDisk pared losses despite record margins.

Piero Cingari

Crude Oil Gains 2%; Keurig Dr Pepper Earnings Top Views

Dow drops over 300 points, NASDAQ down 0.05% and S&P 500 down 0.19%. Keurig Dr Pepper reports strong Q2 results. Energy sector up, real estate down.

Avi Kapoor

Motorola Solutions Posts Upbeat Q2 Earnings, Joins Insmed, Diodes, Parker-Hannifin And Other Big Stocks Moving Higher On Thursday

US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporting strong Q2 results & raised guidance.

Avi Kapoor

This Insmed Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts change outlook on top stocks. For analyst rating changes, see https://www.benzinga.com/analyst-stock-ratings. INSM initiated with $192 PT.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-778.92M

Investing Cash Flow (TTM)

-82.79M

Financing Cash Flow (TTM)

123.96M

Free Cash Flow (TTM)

-807.67M

Capital Expenditure (TTM)

-28.75M

Net Change in Cash (TTM)

-737.75M

Analyst Trends and Forecast

4

May

3

Jun

3

Jul

5

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$25.93B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

22.91

PB Ratio (TTM)

35.00

Earnings Yield % (TTM)

-3.39%

Earnings Yield % (FWD)

-1.75%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$3.47

Company Debt

Total Debt

$543.51M

LT Debt

$543.51M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$3.15M

Total Cash

$544.77M

Debt to Equity

0.77

Issuance of Debt (TTM)

-$3.15M

Repayment of Debt (TTM)

-$3.15M

Key Statistics

Open

-

Close

$121.39

Volume / Avg.

867.00 / 3.43M

Day Range

- - -

52 Wk Range

90.39 - 212.75

Market Cap

$28.07B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

60

Short Interest

5.62%

Days to Cover

2.66

About

Sector

Health Care

Industry

Biotechnology

Insmed Inc is a biopharmaceutical company. Its commercial portfolio and clinical pipeline are organized around three therapeutic areas: Respiratory, Immunology and Inflammation, and Neuro and Other Rare. The company's two commercial products, Arikayc...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Insmed (INSM) stock?

A

You can purchase shares of Insmed (NASDAQ:INSM) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Insmed (INSM) competitors?

A

Other companies in Insmed’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Insmed (INSM) stock?

A

Insmed has a consensus price target of $199.19.

Q

What is the current price for Insmed (INSM)?

A

The stock price for Insmed (NASDAQ: INSM) is $128.52 last updated August 28, 2026 at 4:00 AM EDT.

Q

Does Insmed (INSM) pay a dividend?

A

There are no upcoming dividends for Insmed.

Q

When is Insmed (NASDAQ:INSM) reporting earnings?

A

Insmed does not have any upcoming earnings scheduled.

Q

Is Insmed (INSM) going to split?

A

There is no upcoming split for Insmed.

Q

What sector and industry does Insmed (INSM) operate in?

A

Insmed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.